PNC Financial Services Group
FLNA

PNC Financial Services Group’s Filana Therapeutics FLNA Stock Holding History

PNC Financial Services Group’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.84K Sell
1,681
-51
-3% -$105 ﹤0.01% 4480
2025
Q4 		$3.43K Hold
1,732
– – ﹤0.01% 4374
2025
Q3 		$5.04K Sell
1,732
-483
-22% -$1.11K ﹤0.01% 4202
2025
Q2 		$4.01K Sell
2,215
-103
-4% -$183 ﹤0.01% 4212
2025
Q1 		$3.48K Buy
2,318
+2,202
+1,898% +$5.56K ﹤0.01% 4180
2024
Q4 		$274 Sell
116
-2,222
-95% -$39K ﹤0.01% 4612
2024
Q3 		$68.8K Buy
2,338
+200
+9% +$4.61K ﹤0.01% 2902
2024
Q2 		$26.4K Hold
2,138
– – ﹤0.01% 3344
2024
Q1 		$43.4K Sell
2,138
-20
-0.9% -$461 ﹤0.01% 3056
2023
Q4 		$48.6K Sell
2,158
-127
-6% -$2.68K ﹤0.01% 2989
2023
Q3 		$38K Sell
2,285
-110
-5% -$2.18K ﹤0.01% 3097
2023
Q2 		$58.7K Sell
2,395
-735
-23% -$17.7K ﹤0.01% 2971
2023
Q1 		$75.5K Hold
3,130
– – ﹤0.01% 2750
2022
Q4 		$92.5K Hold
3,130
– – ﹤0.01% 2613
2022
Q3 		$131K Hold
3,130
– – ﹤0.01% 2364
2022
Q2 		$88K Sell
3,130
-1,000
-24% -$25.3K ﹤0.01% 2663
2022
Q1 		$153K Hold
4,130
– – ﹤0.01% 2441
2021
Q4 		$180K Hold
4,130
– – ﹤0.01% 2314
2021
Q3 		$256K Sell
4,130
-253
-6% -$21.1K ﹤0.01% 2033
2021
Q2 		$374K Buy
4,383
+2,358
+116% +$126K ﹤0.01% 1807
2021
Q1 		$91K Buy
+2,025
New +$79.6K ﹤0.01% 2634
2015
Q4 		– Sell
-81
Closed -$1K – 4554
2015
Q3 		$1K Hold
81
– – ﹤0.01% 4490
2015
Q2 		$1K Buy
81
+34
+72% +$466 ﹤0.01% 4571
2015
Q1 		$1K Sell
47
-83
-64% -$1.12K ﹤0.01% 4516
2014
Q4 		$2K Buy
+130
New +$2.25K ﹤0.01% 3825

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

PNC Financial Services Group's FLNA Position: Q1 2026 in Review

PNC Financial Services Group reduced its Filana Therapeutics (FLNA) stake by 2.9% in Q1 2026, selling an estimated $105 and leaving 1,681 shares worth $2.84K. The position accounts for ﹤0.01% of the portfolio, ranked #4480.

PNC Financial Services Group first reported a position in FLNA in Q4 2014 and has held it in 25 quarters since. The position peaked at $374K in Q2 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • PNC Financial Services Group held 1,681 shares of Filana Therapeutics worth $2.84K as of Q1 2026.
  • PNC Financial Services Group sold 51 Filana Therapeutics shares in Q1 2026, an estimated $105.
  • Filana Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4480 holding.
  • PNC Financial Services Group first reported a position in Filana Therapeutics in Q4 2014 and has held it in 25 quarters since.
  • PNC Financial Services Group's Filana Therapeutics position peaked at $374K in Q2 2021.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.